Lifevantage Stock Discussion

Raymond Greer's appointment is viewed as a way to ensure robust leadership and continuity, owing to his deep knowledge of the business and lengthy industry experience. The maneuver is deemed auspicious given LifeVantage's significant momentum.

LifeVantage's dividend reliability is questionable due to continuous EPS decline, posing potential risk to long-term investors.

Management is confident in executing their LV360 strategy, delivering growth and value for stockholders, acknowledging persistent work ahead. Investors' support, both large institutional and smaller individual, was appreciated.

The CEO's inflated compensation doesn't match the company's poor performance. Shareholders may question the management at the AGM, as rising CEO pay contrasts with falling EPS and shareholder losses.

$Lifevantage (LFVN.US)$  turn around not over yet, the little drama is almost over 6th November.